CARBOXYMETHYLCELLULOSE SODIUM

CARBOXYMETHYLCELLULOSE SODIUM was reported 5689 times

CARBOXYMETHYLCELLULOSE SODIUM is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 VAGINAL FLATULENCE 122 0.4026
1 PERIUMBILICAL ABSCESS 12 0.1791
2 NAIL BED INFLAMMATION 37 0.1160
3 FEMALE GENITAL TRACT FISTULA 124 0.0726
4 CATHETER SITE ABSCESS 12 0.0690
5 NASAL MUCOSAL DISORDER 36 0.0617
6 CORNEAL OPERATION 5 0.0485
7 RADICULOPATHY 124 0.0470
8 CHRONIC SINUSITIS 168 0.0447
9 PROCTITIS 123 0.0439
10 SYMBLEPHARON 11 0.0421
11 KERATOMILEUSIS 10 0.0389
12 STREPTOCOCCAL SEPSIS 42 0.0354
13 MACULAR DEGENERATION 417 0.0349
14 VAGINAL LESION 10 0.0327
15 PSEUDOMONAL SEPSIS 43 0.0245
16 EYELID PAIN 49 0.0241
17 INTRAOCULAR LENS IMPLANT 11 0.0222
18 SCLERAL HYPERAEMIA 15 0.0220
19 CHEMICAL BURNS OF EYE 6 0.0216
20 INSTILLATION SITE PRURITUS 8 0.0212
21 PERIORBITAL PAIN 16 0.0189
22 EYELID OPERATION 5 0.0187
23 INSTILLATION SITE REACTION 20 0.0183
24 FOREIGN BODY SENSATION IN EYES 107 0.0168
25 CORNEAL TRANSPLANT 13 0.0166
26 FOREIGN BODY IN EYE 15 0.0156
27 INSTILLATION SITE ERYTHEMA 8 0.0152
28 LACRIMATION DECREASED 7 0.0147
29 LAGOPHTHALMOS 6 0.0147
30 PANCREATIC PSEUDOCYST 11 0.0142
31 CORNEAL EPITHELIUM DEFECT 8 0.0138
32 SUPERFICIAL INJURY OF EYE 15 0.0137
33 MEIBOMIAN GLAND DYSFUNCTION 6 0.0132
34 MONOCYTOSIS 8 0.0129
35 EYELID IRRITATION 31 0.0123
36 PANCREATITIS RELAPSING 10 0.0122
37 VAGINAL DISCHARGE 123 0.0121
38 INSTILLATION SITE PAIN 30 0.0121
39 CORNEAL SCAR 6 0.0119
40 PARAESTHESIA ORAL 170 0.0118
41 INJURY CORNEAL 6 0.0115
42 PRODUCT DROPPER ISSUE 9 0.0114
43 ORAL CANDIDIASIS 139 0.0105
44 CORNEAL ABRASION 14 0.0102
45 EYELID EXFOLIATION 8 0.0101
46 VASCULAR DEVICE INFECTION 42 0.0092
47 EYE IRRITATION 515 0.0089
48 EYELID MARGIN CRUSTING 25 0.0086
49 BILIARY SEPSIS 4 0.0086
50 EYE DISCHARGE 86 0.0083
51 EYE PAIN 465 0.0082
52 PARONYCHIA 36 0.0082
53 VARICOSE VEIN 42 0.0081
54 ULCERATIVE KERATITIS 22 0.0080
55 PANCREATIC CYST 15 0.0078
56 ERYTHEMA OF EYELID 41 0.0076
57 ABNORMAL SENSATION IN EYE 32 0.0074
58 CORNEAL EROSION 4 0.0074
59 ENDOCRINE OPHTHALMOPATHY 6 0.0069
60 EYELIDS PRURITUS 20 0.0064
61 OCULAR DISCOMFORT 70 0.0062
62 PROCEDURAL PAIN 170 0.0061
63 PRODUCT CONTAINER ISSUE 52 0.0061
64 CATARACT NUCLEAR 4 0.0060
65 METASTASES TO LYMPH NODES 40 0.0059
66 INSTILLATION SITE IRRITATION 7 0.0059
67 EYE COLOUR CHANGE 6 0.0059
68 EYE OPERATION 27 0.0059
69 CHEST INJURY 12 0.0058
70 BLOOD PRESSURE DIASTOLIC ABNORMAL 14 0.0055
71 BLEPHARITIS 22 0.0055
72 CONJUNCTIVAL HYPERAEMIA 19 0.0053
73 EYE INJURY 16 0.0053
74 MULTIPLE USE OF SINGLE-USE PRODUCT 29 0.0052
75 CORNEAL DISORDER 11 0.0050
76 DRY EYE 248 0.0050
77 IIIRD NERVE PARALYSIS 4 0.0049
78 OCULAR HYPERAEMIA 233 0.0049
79 FREQUENT BOWEL MOVEMENTS 128 0.0047
80 PHOTOPHOBIA 89 0.0047
81 EXPOSURE TO SARS-COV-2 8 0.0047
82 EYE INFECTION 53 0.0047
83 CATARACT 277 0.0046
84 PANCREATITIS CHRONIC 11 0.0046
85 KERATOPATHY 7 0.0044
86 BODY TEMPERATURE FLUCTUATION 9 0.0043
87 NEOVASCULAR AGE-RELATED MACULAR DEGENERATION 6 0.0043
88 LACRIMATION INCREASED 129 0.0043
89 ASTHENOPIA 23 0.0042
90 ANTIBODY TEST ABNORMAL 3 0.0042
91 EYELID SKIN DRYNESS 5 0.0041
92 EYE INFLAMMATION 39 0.0041
93 POST-ACUTE COVID-19 SYNDROME 5 0.0040
94 HORDEOLUM 17 0.0039
95 EYE PRURITUS 132 0.0039
96 EYELID DISORDER 9 0.0039
97 INFUSION SITE IRRITATION 5 0.0039
98 MEDICAL DEVICE IMPLANTATION 6 0.0038
99 GLAUCOMA 71 0.0037
100 INFUSION SITE MASS 4 0.0037
101 BLOOD PRESSURE SYSTOLIC ABNORMAL 9 0.0036
102 CORNEAL OEDEMA 8 0.0036
103 INTRAOCULAR PRESSURE INCREASED 45 0.0035
104 COLITIS 133 0.0035
105 BRAIN OEDEMA 42 0.0033
106 RETINAL TEAR 8 0.0032
107 VITREOUS DETACHMENT 7 0.0032
108 RECTAL HAEMORRHAGE 138 0.0032
109 CAROTID ARTERY DISEASE 4 0.0031
110 CANDIDA INFECTION 53 0.0031
111 DACRYOSTENOSIS ACQUIRED 4 0.0031
112 ANIMAL SCRATCH 3 0.0031
113 CATARACT OPERATION 18 0.0030
114 HERPES OPHTHALMIC 4 0.0030
115 PERIORBITAL SWELLING 17 0.0030
116 SIALOADENITIS 4 0.0029
117 SPONDYLOLISTHESIS 5 0.0029
118 PRODUCT CONTAINER SEAL ISSUE 5 0.0029
119 THERAPEUTIC PROCEDURE 4 0.0029
120 INFUSION RELATED REACTION 189 0.0028
121 DEVICE INFUSION ISSUE 7 0.0028
122 EYE DISORDER 92 0.0028
123 INFUSION SITE BRUISING 6 0.0028
124 COLITIS ULCERATIVE 122 0.0027
125 METASTASES TO CENTRAL NERVOUS SYSTEM 35 0.0027
126 METAMORPHOPSIA 5 0.0027
127 EYELID OEDEMA 31 0.0027
128 KERATITIS 8 0.0026
129 EYE SWELLING 97 0.0026
130 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 185 0.0026
131 NEURITIS 4 0.0026
132 TRICHORRHEXIS 7 0.0025
133 DEAFNESS NEUROSENSORY 8 0.0024
134 PRODUCT DELIVERY MECHANISM ISSUE 13 0.0024
135 HAEMATOCHEZIA 132 0.0024
136 SWELLING OF EYELID 15 0.0024
137 ESCHERICHIA URINARY TRACT INFECTION 10 0.0024
138 CANCER PAIN 6 0.0023
139 BLOOD CHLORIDE DECREASED 6 0.0023
140 MILIARIA 4 0.0023
141 DIASTOLIC DYSFUNCTION 7 0.0023
142 PRODUCT LOT NUMBER ISSUE 5 0.0023
143 VISION BLURRED 309 0.0022
144 VITREOUS FLOATERS 22 0.0022
145 OTOTOXICITY 4 0.0022
146 SKIN FISSURES 42 0.0021
147 ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE 3 0.0021
148 RETINAL DETACHMENT 19 0.0021
149 LIQUID PRODUCT PHYSICAL ISSUE 15 0.0021
150 COCCYDYNIA 3 0.0020
151 DYSPEPSIA 199 0.0020
152 BLOOD PRESSURE SYSTOLIC DECREASED 9 0.0020
153 SPINAL FUSION SURGERY 8 0.0020
154 EYE CONTUSION 4 0.0019
155 GESTATIONAL DIABETES 9 0.0019
156 SKIN WRINKLING 5 0.0018
157 INVASIVE DUCTAL BREAST CARCINOMA 5 0.0018
158 RHINALGIA 5 0.0018
159 DIFFUSE LARGE B-CELL LYMPHOMA RECURRENT 4 0.0018
160 NECK MASS 5 0.0018
161 INFUSION SITE SWELLING 11 0.0017
162 ORAL SURGERY 4 0.0017
163 HAEMORRHAGIC DIATHESIS 6 0.0017
164 AORTIC VALVE STENOSIS 3 0.0017
165 PRODUCT USE COMPLAINT 26 0.0016
166 EYE HAEMORRHAGE 22 0.0016
167 NASAL DRYNESS 10 0.0016
168 VISUAL ACUITY REDUCED 53 0.0016
169 INFUSION SITE PRURITUS 5 0.0016
170 PRODUCT ADMINISTRATION ERROR 32 0.0016
171 PARKINSON'S DISEASE 4 0.0016
172 RETINAL DISORDER 4 0.0015
173 BREAST ENLARGEMENT 5 0.0015
174 NAIL DISCOLOURATION 6 0.0015
175 INTERVERTEBRAL DISC DEGENERATION 14 0.0015
176 ALLERGIC REACTION TO EXCIPIENT 3 0.0015
177 PRODUCT LABEL ISSUE 10 0.0015
178 WOUND COMPLICATION 5 0.0015
179 TENOSYNOVITIS 4 0.0014
180 HAEMORRHOIDAL HAEMORRHAGE 7 0.0014
181 C-REACTIVE PROTEIN INCREASED 52 0.0014
182 THROMBOPHLEBITIS 5 0.0014
183 BLINDNESS UNILATERAL 20 0.0014
184 ANEURYSM 7 0.0014
185 NEUTROPENIC SEPSIS 10 0.0014
186 PRODUCT PACKAGING ISSUE 13 0.0014
187 SINUS HEADACHE 8 0.0013
188 PROTEIN TOTAL DECREASED 5 0.0013
189 EXPIRED PRODUCT ADMINISTERED 44 0.0013
190 BODY TEMPERATURE DECREASED 13 0.0013
191 THERAPEUTIC PRODUCT EFFECT DELAYED 6 0.0013
192 RESTLESSNESS 48 0.0013
193 BUNDLE BRANCH BLOCK RIGHT 6 0.0013
194 OESOPHAGEAL DISORDER 5 0.0013
195 EAR PAIN 25 0.0013
196 EYELID PTOSIS 13 0.0013
197 WOUND SECRETION 5 0.0013
198 PHOTOPSIA 8 0.0013
199 BLADDER PAIN 4 0.0013
200 RECALLED PRODUCT ADMINISTERED 12 0.0013
201 IMMUNOSUPPRESSION 11 0.0012
202 VULVOVAGINAL DRYNESS 4 0.0012
203 VISUAL IMPAIRMENT 152 0.0012
204 BLOOD PRESSURE DIASTOLIC DECREASED 9 0.0012
205 SKIN WARM 7 0.0012
206 ANGLE CLOSURE GLAUCOMA 3 0.0012
207 LUNG NEOPLASM 5 0.0012
208 EAR DISCOMFORT 12 0.0012
209 INCREASED UPPER AIRWAY SECRETION 6 0.0012
210 PSEUDOMONAS INFECTION 10 0.0012
211 AORTIC ARTERIOSCLEROSIS 3 0.0012
212 CONCUSSION 9 0.0012
213 ACTINIC KERATOSIS 3 0.0012
214 FAILURE TO THRIVE 6 0.0012
215 TOOTH INJURY 5 0.0012
216 CAROTID ARTERY STENOSIS 4 0.0011
217 SPINAL OSTEOARTHRITIS 10 0.0011
218 NASAL DISCOMFORT 9 0.0011
219 MACULOPATHY 4 0.0011
220 BLOOD PRESSURE FLUCTUATION 27 0.0011
221 PRE-EXISTING CONDITION IMPROVED 7 0.0011
222 CHRONIC GRAFT VERSUS HOST DISEASE 4 0.0011
223 VISUAL FIELD DEFECT 8 0.0011
224 MUSCULOSKELETAL CHEST PAIN 17 0.0011
225 EAR DISORDER 5 0.0011
226 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 3 0.0011
227 BLINDNESS TRANSIENT 8 0.0011
228 BLINDNESS 44 0.0011
229 CONJUNCTIVITIS 20 0.0011
230 ARTHRITIS INFECTIVE 5 0.0011
231 SEASONAL ALLERGY 15 0.0011
232 SPINAL COLUMN STENOSIS 5 0.0011
233 SKIN ABRASION 5 0.0011
234 PARANASAL SINUS DISCOMFORT 4 0.0011
235 CONJUNCTIVAL HAEMORRHAGE 4 0.0010
236 PYELONEPHRITIS 9 0.0010
237 WEIGHT DECREASED 288 0.0010
238 BODY HEIGHT DECREASED 11 0.0010
239 FAECES HARD 4 0.0010
240 POOR QUALITY SLEEP 22 0.0010
241 URINE ODOUR ABNORMAL 6 0.0010
242 CONSTIPATION 221 0.0010
243 WRONG DRUG ADMINISTERED 9 0.0010
244 FACIAL PAIN 9 0.0010
245 CARPAL TUNNEL SYNDROME 14 0.0010
246 SLEEP APNOEA SYNDROME 19 0.0010
247 TRIGGER FINGER 4 0.0010
248 ECZEMA 51 0.0010
249 SPINAL STENOSIS 4 0.0010
250 DERMATITIS CONTACT 11 0.0010
251 RED CELL DISTRIBUTION WIDTH INCREASED 4 0.0010
252 BLOOD BLISTER 3 0.0010
253 SINUS DISORDER 19 0.0010
254 ERYTHEMA 196 0.0010
255 ARTHROPOD BITE 7 0.0009
256 BILE DUCT STONE 3 0.0009
257 POOR PERIPHERAL CIRCULATION 4 0.0009
258 RETCHING 20 0.0009
259 INFUSION SITE PAIN 12 0.0009
260 BREAST CANCER METASTATIC 10 0.0009
261 TENSION HEADACHE 4 0.0009
262 BRUXISM 5 0.0009
263 ANAEMIA 176 0.0009
264 HYPERLIPIDAEMIA 11 0.0009
265 ACIDOSIS 7 0.0009
266 DIVERTICULUM INTESTINAL 4 0.0009
267 DEVICE USE ISSUE 16 0.0009
268 DISABILITY 18 0.0009
269 INTENTIONAL DEVICE MISUSE 4 0.0009
270 APPETITE DISORDER 6 0.0009
271 PHYSICAL DISABILITY 4 0.0009
272 PLEURAL EFFUSION 55 0.0009
273 BRONCHOPULMONARY ASPERGILLOSIS 7 0.0009
274 BLOOD SODIUM DECREASED 17 0.0009
275 PELVIC FRACTURE 7 0.0009
276 RHINITIS ALLERGIC 4 0.0009
277 THERAPY PARTIAL RESPONDER 14 0.0009
278 LEFT VENTRICULAR DYSFUNCTION 6 0.0009
279 BREAST MASS 6 0.0009
280 TOOTHACHE 16 0.0009
281 CARBOHYDRATE ANTIGEN 125 INCREASED 3 0.0009
282 CARDIAC VALVE DISEASE 5 0.0009
283 ONYCHOCLASIS 6 0.0009
284 BRAIN NEOPLASM 8 0.0009
285 HAIR GROWTH ABNORMAL 6 0.0009
286 FORMICATION 6 0.0009
287 AORTIC STENOSIS 3 0.0009
288 RALES 5 0.0009
289 PRODUCT LABEL CONFUSION 5 0.0009
290 MIDDLE INSOMNIA 16 0.0009
291 ABNORMAL FAECES 7 0.0009
292 SCRATCH 9 0.0009
293 DIVERTICULUM 6 0.0008
294 GALLBLADDER DISORDER 15 0.0008
295 INCORRECT PRODUCT STORAGE 11 0.0008
296 TOOTH INFECTION 11 0.0008
297 WRIST FRACTURE 10 0.0008
298 HEARING IMPAIRED 5 0.0008
299 SQUAMOUS CELL CARCINOMA OF SKIN 5 0.0008
300 DIZZINESS POSTURAL 8 0.0008
301 BLOOD PRESSURE SYSTOLIC INCREASED 16 0.0008
302 VITAMIN D DECREASED 7 0.0008
303 CEREBRAL DISORDER 6 0.0008
304 PIGMENTATION DISORDER 5 0.0008
305 EXPIRED DRUG ADMINISTERED 4 0.0008
306 DYSPHORIA 4 0.0008
307 CORONARY ARTERIAL STENT INSERTION 4 0.0008
308 ABDOMINAL PAIN 182 0.0008
309 ROTATOR CUFF SYNDROME 10 0.0008
310 BENIGN PROSTATIC HYPERPLASIA 4 0.0008
311 VASCULITIS 9 0.0008
312 HEART RATE DECREASED 27 0.0008
313 TENDERNESS 8 0.0008
314 MULTIPLE ALLERGIES 6 0.0008
315 WEIGHT FLUCTUATION 8 0.0008
316 HYPOGAMMAGLOBULINAEMIA 5 0.0008
317 DYSGRAPHIA 5 0.0008
318 NERVE COMPRESSION 7 0.0008
319 WALKING AID USER 5 0.0008
320 OSTEOARTHRITIS 32 0.0008
321 CLOSTRIDIUM DIFFICILE COLITIS 8 0.0008
322 CANDIDIASIS 3 0.0007
323 SENSORY LOSS 6 0.0007
324 DRY MOUTH 60 0.0007
325 PULMONARY MASS 11 0.0007
326 UPPER-AIRWAY COUGH SYNDROME 6 0.0007
327 SINUS BRADYCARDIA 7 0.0007
328 LYMPHOEDEMA 5 0.0007
329 PRODUCT PHYSICAL CONSISTENCY ISSUE 4 0.0007
330 HIP FRACTURE 23 0.0007
331 PHARYNGEAL OEDEMA 11 0.0007
332 PRODUCT LEAKAGE 4 0.0007
333 PRODUCTIVE COUGH 34 0.0007
334 INFUSION SITE ERYTHEMA 6 0.0007
335 PAPULE 5 0.0007
336 PYREXIA 245 0.0007
337 BUNDLE BRANCH BLOCK LEFT 3 0.0007
338 IMPAIRED DRIVING ABILITY 8 0.0007
339 SALIVARY HYPERSECRETION 7 0.0007
340 GRAFT VERSUS HOST DISEASE 5 0.0007
341 HEAD INJURY 22 0.0007
342 MADAROSIS 8 0.0007
343 DRY THROAT 7 0.0007
344 RASH PUSTULAR 5 0.0007
345 BLOOD ALKALINE PHOSPHATASE INCREASED 17 0.0007
346 GRIP STRENGTH DECREASED 6 0.0007
347 GLUCOSE TOLERANCE IMPAIRED 4 0.0007
348 LOWER GASTROINTESTINAL HAEMORRHAGE 5 0.0007
349 MALAISE 296 0.0007
350 SKIN HAEMORRHAGE 10 0.0007
351 PULMONARY HYPERTENSION 14 0.0007
352 SNEEZING 15 0.0007
353 THROAT TIGHTNESS 18 0.0007
354 RHINORRHOEA 43 0.0007
355 PRODUCT TASTE ABNORMAL 9 0.0007
356 LEUKOCYTOSIS 12 0.0007
357 LIP DRY 6 0.0007
358 BLOOD THYROID STIMULATING HORMONE DECREASED 3 0.0007
359 ABDOMINAL HERNIA 3 0.0007
360 RENAL FAILURE CHRONIC 5 0.0006
361 BLOOD PRESSURE DIASTOLIC INCREASED 3 0.0006
362 DEVICE RELATED INFECTION 10 0.0006
363 SPINAL OPERATION 8 0.0006
364 CONCOMITANT DISEASE AGGRAVATED 4 0.0006
365 APHONIA 9 0.0006
366 THINKING ABNORMAL 12 0.0006
367 WOUND 18 0.0006
368 SKIN LACERATION 7 0.0006
369 ERYTHEMA MULTIFORME 6 0.0006
370 EPISTAXIS 48 0.0006
371 BASAL CELL CARCINOMA 10 0.0006
372 SECRETION DISCHARGE 8 0.0006
373 BLOOD GLUCOSE FLUCTUATION 7 0.0006
374 ARTERIOSCLEROSIS 6 0.0006
375 PRODUCT ADMINISTRATION INTERRUPTED 5 0.0006
376 BLEPHAROSPASM 4 0.0006
377 TOOTH FRACTURE 7 0.0006
378 SPINAL DISORDER 6 0.0006
379 TRICUSPID VALVE INCOMPETENCE 5 0.0006
380 HYPOACUSIS 27 0.0006
381 ATRIAL FLUTTER 5 0.0006
382 HYPOTHYROIDISM 20 0.0006
383 RHINITIS 5 0.0006
384 DYSGEUSIA 46 0.0006
385 POOR QUALITY DRUG ADMINISTERED 4 0.0006
386 MUSCLE DISORDER 5 0.0006
387 DYSPHONIA 36 0.0006
388 VITAMIN D DEFICIENCY 6 0.0006
389 HAEMORRHOIDS 12 0.0006
390 DECUBITUS ULCER 5 0.0006
391 MICTURITION URGENCY 7 0.0006
392 FEELING COLD 17 0.0006
393 HYPERAESTHESIA 5 0.0006
394 HOSPICE CARE 6 0.0006
395 PRODUCT FORMULATION ISSUE 4 0.0006
396 SARS-COV-2 TEST POSITIVE 8 0.0006
397 INABILITY TO AFFORD MEDICATION 6 0.0006
398 URINARY TRACT INFECTION 103 0.0006
399 IMMUNODEFICIENCY 9 0.0006
400 EOSINOPHIL COUNT INCREASED 5 0.0006
401 SKIN MASS 4 0.0006
402 BURNING SENSATION 42 0.0006
403 HAIR TEXTURE ABNORMAL 8 0.0006
404 BRONCHIECTASIS 4 0.0006
405 WRONG PRODUCT ADMINISTERED 4 0.0006
406 ULCER HAEMORRHAGE 4 0.0006
407 BACTERAEMIA 7 0.0006
408 BACTERIAL INFECTION 11 0.0006
409 LIMB INJURY 16 0.0006
410 TOOTH DISORDER 13 0.0006
411 EYE MOVEMENT DISORDER 4 0.0006
412 OSTEOPOROSIS 24 0.0006
413 RIB FRACTURE 12 0.0006
414 TEMPERATURE INTOLERANCE 6 0.0006
415 DRUG INEFFECTIVE 759 0.0006
416 ARTHROPATHY 32 0.0006
417 HEART RATE IRREGULAR 13 0.0006
418 PRODUCT ODOUR ABNORMAL 6 0.0006
419 CONTUSION 55 0.0006
420 HEADACHE 358 0.0006
421 BLOOD CALCIUM INCREASED 5 0.0006
422 SKIN DISORDER 19 0.0006
423 GROIN PAIN 5 0.0006
424 POOR QUALITY PRODUCT ADMINISTERED 6 0.0006
425 JOINT DISLOCATION 6 0.0006
426 BALANCE DISORDER 49 0.0006
427 RESPIRATORY TRACT CONGESTION 9 0.0006
428 TINNITUS 26 0.0006
429 HEAD DISCOMFORT 10 0.0006
430 THERMAL BURN 4 0.0006
431 RESPIRATORY RATE INCREASED 5 0.0006
432 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 40 0.0006
433 KIDNEY INFECTION 11 0.0006
434 BACK PAIN 130 0.0006
435 DYSPNOEA EXERTIONAL 21 0.0006
436 GASTROENTERITIS VIRAL 10 0.0006
437 TONGUE DISORDER 4 0.0006
438 MUSCLE ATROPHY 7 0.0006
439 NAUSEA 437 0.0006
440 PAIN 339 0.0006
441 BACK INJURY 6 0.0006
442 HYPOKINESIA 8 0.0006
443 FAECES SOFT 4 0.0005
444 UTERINE LEIOMYOMA 4 0.0005
445 CHOKING SENSATION 3 0.0005
446 ANOREXIA 7 0.0005
447 LABORATORY TEST ABNORMAL 16 0.0005
448 UROSEPSIS 5 0.0005
449 LIP SWELLING 18 0.0005
450 DIPLOPIA 14 0.0005
451 SEPSIS 60 0.0005
452 ORAL PAIN 12 0.0005
453 CELLULITIS 27 0.0005
454 ACUTE PULMONARY OEDEMA 3 0.0005
455 HEMIPARESIS 9 0.0005
456 MITRAL VALVE INCOMPETENCE 6 0.0005
457 ECONOMIC PROBLEM 8 0.0005
458 FOOT FRACTURE 10 0.0005
459 DEVICE FAILURE 8 0.0005
460 BLOOD PRESSURE INCREASED 80 0.0005
461 LIPASE INCREASED 4 0.0005
462 NECK PAIN 29 0.0005
463 SINUS CONGESTION 7 0.0005
464 STAPHYLOCOCCAL INFECTION 17 0.0005
465 ABDOMINAL PAIN LOWER 13 0.0005
466 DYSSTASIA 15 0.0005
467 BRONCHITIS 38 0.0005
468 SWOLLEN TONGUE 16 0.0005
469 DECREASED IMMUNE RESPONSIVENESS 5 0.0005
470 AFFECTIVE DISORDER 4 0.0005
471 BLOOD IRON DECREASED 6 0.0005
472 THIRST 9 0.0005
473 ORAL DISCOMFORT 7 0.0005
474 SKIN ULCER 13 0.0005
475 CYSTITIS 16 0.0005
476 SCIATICA 8 0.0005
477 FLUSHING 51 0.0005
478 SPINAL FRACTURE 10 0.0005
479 BLOOD PRESSURE INADEQUATELY CONTROLLED 3 0.0005
480 OBSESSIVE-COMPULSIVE DISORDER 4 0.0005
481 DEAFNESS 13 0.0005
482 NIGHT SWEATS 16 0.0005
483 EMPHYSEMA 5 0.0005
484 WRONG TECHNIQUE IN DRUG USAGE PROCESS 18 0.0005
485 TASTE DISORDER 10 0.0005
486 OFF LABEL USE 431 0.0005
487 POST PROCEDURAL INFECTION 4 0.0005
488 INTENTIONAL PRODUCT USE ISSUE 43 0.0005
489 ANGINA PECTORIS 14 0.0005
490 NEUTROPHIL COUNT INCREASED 5 0.0005
491 SINUSITIS 50 0.0005
492 CARDIOMEGALY 6 0.0005
493 IMPAIRED HEALING 16 0.0005
494 INITIAL INSOMNIA 5 0.0005
495 INJECTION SITE EXTRAVASATION 6 0.0005
496 OROPHARYNGEAL PAIN 45 0.0005
497 DYSPHAGIA 46 0.0005
498 PHARYNGITIS 6 0.0005
499 HYPERTHYROIDISM 7 0.0005
500 HYPOXIA 17 0.0005
501 FLUID OVERLOAD 7 0.0005
502 OXYGEN SATURATION DECREASED 27 0.0005
503 POLLAKIURIA 20 0.0005
504 URINARY RETENTION 16 0.0005
505 NASAL CONGESTION 28 0.0005
506 TRANSIENT ISCHAEMIC ATTACK 16 0.0005
507 RENAL PAIN 5 0.0005
508 INCREASED APPETITE 9 0.0005
509 ARTHRITIS 37 0.0005
510 HYPOPHAGIA 12 0.0005
511 DRUG PRESCRIBING ERROR 9 0.0005
512 MENTAL STATUS CHANGES 13 0.0005
513 THERAPEUTIC RESPONSE UNEXPECTED 21 0.0005
514 MYDRIASIS 6 0.0005
515 COUGH 131 0.0005
516 INSOMNIA 124 0.0005
517 ERUCTATION 9 0.0005
518 PRODUCT QUALITY ISSUE 63 0.0005
519 BLISTER 26 0.0005
520 CARDIAC MURMUR 4 0.0005
521 OSTEOPENIA 7 0.0005
522 FAECES DISCOLOURED 10 0.0005
523 SWELLING FACE 30 0.0005
524 NERVOUSNESS 24 0.0005
525 PULMONARY THROMBOSIS 5 0.0005
526 FLATULENCE 26 0.0005
527 MUSCULOSKELETAL PAIN 24 0.0005
528 SPEECH DISORDER 24 0.0005
529 DRUG DISPENSING ERROR 7 0.0005
530 URINE OUTPUT DECREASED 4 0.0005
531 WOUND INFECTION 5 0.0005
532 ASPIRATION 5 0.0005
533 BEDRIDDEN 6 0.0005
534 UPPER RESPIRATORY TRACT INFECTION 21 0.0005
535 THYROID DISORDER 7 0.0005
536 UPPER LIMB FRACTURE 9 0.0005
537 FOOT DEFORMITY 5 0.0005
538 CARDIAC FAILURE ACUTE 3 0.0004
539 OBSTRUCTIVE AIRWAYS DISORDER 5 0.0004
540 GAIT DISTURBANCE 86 0.0004
541 CYTOKINE RELEASE SYNDROME 9 0.0004
542 FALL 149 0.0004
543 HYPOAESTHESIA 67 0.0004
544 MALNUTRITION 5 0.0004
545 GLOSSODYNIA 10 0.0004
546 THROAT IRRITATION 20 0.0004
547 BLOOD CALCIUM DECREASED 5 0.0004
548 SURGERY 26 0.0004
549 OEDEMA PERIPHERAL 54 0.0004
550 VERTIGO 27 0.0004
551 OROPHARYNGEAL DISCOMFORT 4 0.0004
552 DISCOMFORT 27 0.0004
553 NEUROPATHY PERIPHERAL 42 0.0004
554 ATRIAL FIBRILLATION 43 0.0004
555 MUSCULAR WEAKNESS 50 0.0004
556 URINARY INCONTINENCE 13 0.0004
557 PNEUMONIA BACTERIAL 4 0.0004
558 CHILLS 51 0.0004
559 NEOPLASM 5 0.0004
560 INCREASED TENDENCY TO BRUISE 4 0.0004
561 DYSURIA 16 0.0004
562 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 88 0.0004
563 OVARIAN CANCER 4 0.0004
564 THERAPY INTERRUPTED 31 0.0004
565 PRODUCT DISTRIBUTION ISSUE 4 0.0004
566 APHASIA 13 0.0004
567 DISORIENTATION 17 0.0004
568 BLOOD TEST ABNORMAL 6 0.0004
569 CHOLELITHIASIS 14 0.0004
570 MUSCLE SPASMS 78 0.0004
571 PAIN IN JAW 12 0.0004
572 PHARMACEUTICAL PRODUCT COMPLAINT 11 0.0004
573 COVID-19 PNEUMONIA 5 0.0004
574 NASOPHARYNGITIS 78 0.0004
575 THROMBOSIS 34 0.0004
576 RESPIRATORY TRACT INFECTION 11 0.0004
577 DYSPNOEA 239 0.0004
578 FEBRILE NEUTROPENIA 28 0.0004
579 LIMB DISCOMFORT 13 0.0004
580 FATIGUE 327 0.0004
581 IRRITABLE BOWEL SYNDROME 9 0.0004
582 CHOLECYSTITIS 5 0.0004
583 POST PROCEDURAL COMPLICATION 8 0.0004
584 PANCREATITIS 22 0.0004
585 PNEUMONIA 134 0.0004
586 SKIN DISCOLOURATION 19 0.0004
587 EAR INFECTION 11 0.0004
588 CLOSTRIDIUM DIFFICILE INFECTION 9 0.0004
589 ABDOMINAL DISTENSION 43 0.0004
590 FIBROMYALGIA 10 0.0004
591 CHOKING 8 0.0004
592 ACCIDENTAL OVERDOSE 15 0.0004
593 BONE PAIN 24 0.0004
594 MIGRAINE 39 0.0004
595 CYTOPENIA 5 0.0004
596 ASTHENIA 153 0.0004
597 CARDIOMYOPATHY 6 0.0004
598 MYALGIA 69 0.0004
599 COVID-19 71 0.0004
600 HAEMATOCRIT DECREASED 8 0.0004
601 BLOOD PRESSURE ABNORMAL 8 0.0004
602 ORTHOSTATIC HYPOTENSION 7 0.0004
603 AGEUSIA 10 0.0004
604 INJECTION SITE DISCOLOURATION 5 0.0004
605 PRODUCT STORAGE ERROR 35 0.0004
606 INTENTIONAL PRODUCT MISUSE 35 0.0004
607 BLOOD POTASSIUM DECREASED 12 0.0004
608 DYSARTHRIA 15 0.0004
609 HOT FLUSH 30 0.0004
610 GASTROOESOPHAGEAL REFLUX DISEASE 32 0.0004
611 COLD SWEAT 7 0.0004
612 PRODUCT AVAILABILITY ISSUE 9 0.0004
613 FEEDING DISORDER 8 0.0004
614 HEART RATE INCREASED 39 0.0004
615 TOOTH ABSCESS 4 0.0004
616 SUBARACHNOID HAEMORRHAGE 4 0.0004
617 NEUTROPHIL COUNT DECREASED 16 0.0004
618 HIP ARTHROPLASTY 6 0.0004
619 DRUG ADMINISTRATION ERROR 12 0.0004
620 FUNGAL INFECTION 13 0.0004
621 ERECTILE DYSFUNCTION 10 0.0004
622 OEDEMA 21 0.0004
623 PAIN IN EXTREMITY 114 0.0004
624 INTERNATIONAL NORMALISED RATIO INCREASED 11 0.0004
625 APNOEA 3 0.0004
626 ACUTE MYELOID LEUKAEMIA 6 0.0004
627 RED BLOOD CELL COUNT DECREASED 11 0.0004
628 PRODUCT DOSE OMISSION ISSUE 113 0.0004
629 PLATELET COUNT INCREASED 5 0.0004
630 PRODUCT DOSE OMISSION 25 0.0004
631 MUCOSAL INFLAMMATION 10 0.0004
632 CHEST DISCOMFORT 39 0.0004
633 HAEMOGLOBIN DECREASED 39 0.0004
634 PNEUMOTHORAX 6 0.0004
635 HEPATIC STEATOSIS 7 0.0004
636 PARAESTHESIA 59 0.0004
637 QUALITY OF LIFE DECREASED 5 0.0004
638 INCORRECT DOSE ADMINISTERED 85 0.0004
639 RASH MACULAR 13 0.0004
640 PAIN OF SKIN 10 0.0004
641 NEPHROLITHIASIS 17 0.0004
642 PRURITUS GENERALISED 8 0.0004
643 ALTERED STATE OF CONSCIOUSNESS 8 0.0004
644 HYPERTENSION 78 0.0004
645 MUSCULOSKELETAL DISORDER 7 0.0004
646 SKIN EXFOLIATION 31 0.0004
647 LUNG NEOPLASM MALIGNANT 15 0.0004
648 WHITE BLOOD CELL COUNT INCREASED 14 0.0004
649 ACUTE RESPIRATORY FAILURE 7 0.0004
650 PHOTOSENSITIVITY REACTION 6 0.0004
651 APPLICATION SITE PAIN 8 0.0004
652 DIZZINESS 181 0.0004
653 DENTAL CARIES 4 0.0004
654 CYTOMEGALOVIRUS INFECTION 6 0.0004
655 PRURITUS 138 0.0004
656 BLOOD UREA INCREASED 6 0.0004
657 HALLUCINATION 27 0.0004
658 DRUG DOSE OMISSION 59 0.0004
659 FEMUR FRACTURE 11 0.0004
660 WHEEZING 21 0.0004
661 MUSCULOSKELETAL STIFFNESS 31 0.0004
662 DRY SKIN 47 0.0004
663 PRODUCT USE ISSUE 66 0.0004
664 SCAB 4 0.0004
665 SUBDURAL HAEMATOMA 5 0.0003
666 CARDIAC OPERATION 3 0.0003
667 UNRESPONSIVE TO STIMULI 9 0.0003
668 MUSCULOSKELETAL DISCOMFORT 6 0.0003
669 HAEMATOMA 9 0.0003
670 GASTROINTESTINAL DISORDER 31 0.0003
671 PERICARDIAL EFFUSION 8 0.0003
672 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 18 0.0003
673 PERIPHERAL SWELLING 53 0.0003
674 LOCAL SWELLING 6 0.0003
675 JOINT STIFFNESS 9 0.0003
676 FEELING HOT 21 0.0003
677 PALPITATIONS 40 0.0003
678 ABDOMINAL DISCOMFORT 57 0.0003
679 SYNCOPE 34 0.0003
680 BLOOD TRIGLYCERIDES INCREASED 6 0.0003
681 ARTHRALGIA 141 0.0003
682 LYMPHADENOPATHY 12 0.0003
683 DRUG EFFECT LESS THAN EXPECTED 5 0.0003
684 RHABDOMYOLYSIS 14 0.0003
685 INTENTIONAL DRUG MISUSE 7 0.0003
686 DIARRHOEA 216 0.0003
687 HAEMORRHAGE INTRACRANIAL 5 0.0003
688 GOUT 6 0.0003
689 POLYNEUROPATHY 4 0.0003
690 HYPERSENSITIVITY 62 0.0003
691 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 60 0.0003
692 KNEE ARTHROPLASTY 7 0.0003
693 VOMITING 156 0.0003
694 INFLUENZA 37 0.0003
695 BLOOD PRESSURE DECREASED 22 0.0003
696 VIRAL INFECTION 11 0.0003
697 PNEUMONITIS 9 0.0003
698 ADRENAL INSUFFICIENCY 4 0.0003
699 NOCTURIA 4 0.0003
700 CHEST PAIN 61 0.0003
701 BONE DISORDER 6 0.0003
702 EATING DISORDER 7 0.0003
703 BLOOD THYROID STIMULATING HORMONE INCREASED 3 0.0003
704 TREMOR 54 0.0003
705 HYPOKALAEMIA 15 0.0003
706 TENDON RUPTURE 4 0.0003
707 HYPERCALCAEMIA 4 0.0003
708 ANKLE FRACTURE 5 0.0003
709 TENDONITIS 5 0.0003
710 DECREASED APPETITE 75 0.0003
711 HEPATIC ENZYME INCREASED 22 0.0003
712 DEHYDRATION 43 0.0003
713 CYST 4 0.0003
714 DEMENTIA 9 0.0003
715 ILEUS 4 0.0003
716 HAIR COLOUR CHANGES 4 0.0003
717 MOBILITY DECREASED 23 0.0003
718 HYPONATRAEMIA 18 0.0003
719 HYPOTENSION 64 0.0003
720 BRAIN FOG 5 0.0003
721 NIGHTMARE 11 0.0003
722 SOMNOLENCE 64 0.0003
723 DELIRIUM 11 0.0003
724 FEELING JITTERY 6 0.0003
725 NEOPLASM MALIGNANT 21 0.0003
726 OBESITY 5 0.0003
727 THERAPEUTIC RESPONSE DECREASED 19 0.0003
728 BLOOD GLUCOSE DECREASED 15 0.0003
729 LOWER LIMB FRACTURE 6 0.0003
730 SENSORY DISTURBANCE 5 0.0003
731 MOVEMENT DISORDER 10 0.0003
732 ROAD TRAFFIC ACCIDENT 13 0.0003
733 ATELECTASIS 3 0.0003
734 HIATUS HERNIA 4 0.0003
735 BLOOD POTASSIUM INCREASED 5 0.0003
736 AUTOIMMUNE DISORDER 3 0.0003
737 COELIAC DISEASE 3 0.0003
738 MEMORY IMPAIRMENT 42 0.0003
739 FEELING ABNORMAL 73 0.0003
740 IMMUNE SYSTEM DISORDER 4 0.0003
741 ABNORMAL BEHAVIOUR 12 0.0003
742 BLADDER DISORDER 3 0.0003
743 PSYCHOMOTOR HYPERACTIVITY 5 0.0003
744 ASPARTATE AMINOTRANSFERASE INCREASED 16 0.0003
745 RHEUMATOID ARTHRITIS 34 0.0003
746 JOINT SWELLING 36 0.0003
747 FULL BLOOD COUNT DECREASED 6 0.0003
748 UPPER GASTROINTESTINAL HAEMORRHAGE 5 0.0003
749 EXTRA DOSE ADMINISTERED 12 0.0003
750 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 10 0.0003
751 UVEITIS 4 0.0003
752 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 5 0.0003
753 PALLOR 8 0.0003
754 ASTHMA 33 0.0003
755 CORONARY ARTERY OCCLUSION 4 0.0003
756 SKIN LESION 8 0.0003
757 ACCIDENTAL EXPOSURE TO PRODUCT 30 0.0003
758 RESPIRATORY DISTRESS 8 0.0003
759 MENTAL IMPAIRMENT 7 0.0003
760 LOSS OF CONSCIOUSNESS 37 0.0003
761 ABDOMINAL PAIN UPPER 59 0.0003
762 DERMATITIS 6 0.0003
763 CARDIAC FAILURE CONGESTIVE 23 0.0003
764 MASS 4 0.0003
765 WEIGHT INCREASED 64 0.0003
766 CONFUSIONAL STATE 46 0.0003
767 INCORRECT DRUG ADMINISTRATION DURATION 8 0.0003
768 DEVICE OCCLUSION 4 0.0003
769 INFECTION 41 0.0003
770 LYMPHOCYTE COUNT DECREASED 5 0.0003
771 BREAST PAIN 3 0.0003
772 BLOOD GLUCOSE INCREASED 53 0.0003
773 ILL-DEFINED DISORDER 17 0.0003
774 LIVER FUNCTION TEST INCREASED 6 0.0003
775 PARALYSIS 4 0.0003
776 HYPERSOMNIA 8 0.0003
777 BLOOD CHOLESTEROL INCREASED 13 0.0003
778 HERPES ZOSTER 16 0.0003
779 IMPAIRED QUALITY OF LIFE 4 0.0003
780 DISTURBANCE IN ATTENTION 15 0.0003
781 LETHARGY 16 0.0003
782 UNEVALUABLE EVENT 21 0.0003
783 RASH PRURITIC 15 0.0003
784 ANOSMIA 4 0.0003
785 PULMONARY ARTERIAL HYPERTENSION 4 0.0003
786 PELVIC PAIN 5 0.0003
787 GASTROINTESTINAL HAEMORRHAGE 23 0.0003
788 RESTLESS LEGS SYNDROME 5 0.0003
789 INTERVERTEBRAL DISC PROTRUSION 6 0.0003
790 PANIC ATTACK 10 0.0003
791 ILLNESS 28 0.0003
792 CEREBROVASCULAR ACCIDENT 46 0.0003
793 ANAPHYLACTIC REACTION 15 0.0003
794 LIVER DISORDER 12 0.0003
795 STEVENS-JOHNSON SYNDROME 6 0.0003
796 GAIT INABILITY 9 0.0003
797 TYPE 2 DIABETES MELLITUS 9 0.0003
798 ADVERSE DRUG REACTION 24 0.0003
799 SWELLING 25 0.0003
800 CHROMATURIA 6 0.0003
801 HYPOAESTHESIA ORAL 4 0.0003
802 STOMATITIS 16 0.0003
803 BLOOD URINE PRESENT 5 0.0003
804 DIABETES MELLITUS 20 0.0003
805 GASTRIC DISORDER 9 0.0003
806 INSURANCE ISSUE 4 0.0003
807 PULMONARY FIBROSIS 5 0.0003
808 BLOOD CREATININE INCREASED 17 0.0003
809 WHITE BLOOD CELL COUNT DECREASED 28 0.0003
810 LUNG INFECTION 4 0.0003
811 EJECTION FRACTION DECREASED 4 0.0003
812 INFLUENZA LIKE ILLNESS 21 0.0003
813 ALOPECIA 50 0.0003
814 RESPIRATORY ARREST 7 0.0003
815 HOSPITALISATION 39 0.0003
816 SYSTEMIC LUPUS ERYTHEMATOSUS 9 0.0003
817 ATAXIA 3 0.0003
818 DIVERTICULITIS 7 0.0003
819 SKIN BURNING SENSATION 18 0.0003
820 SEIZURE 29 0.0003
821 HAEMOPTYSIS 7 0.0003
822 LOCALISED INFECTION 6 0.0002
823 PRODUCT PHYSICAL ISSUE 5 0.0002
824 CRYING 9 0.0002
825 PRODUCT DOSE OMISSION IN ERROR 7 0.0002
826 RESPIRATORY FAILURE 18 0.0002
827 PRESYNCOPE 6 0.0002
828 NEURALGIA 6 0.0002
829 BACK DISORDER 4 0.0002
830 AMNESIA 16 0.0002
831 CARDIAC DISORDER 23 0.0002
832 INJURY ASSOCIATED WITH DEVICE 5 0.0002
833 THERAPY NON-RESPONDER 11 0.0002
834 VENTRICULAR TACHYCARDIA 4 0.0002
835 INJURY 17 0.0002
836 DRUG EFFECT DECREASED 13 0.0002
837 RASH 105 0.0002
838 COAGULOPATHY 4 0.0002
839 DRUG INTOLERANCE 23 0.0002
840 HALLUCINATION, VISUAL 5 0.0002
841 COGNITIVE DISORDER 11 0.0002
842 PLATELET COUNT DECREASED 25 0.0002
843 RESPIRATORY DISORDER 7 0.0002
844 SCAR 4 0.0002
845 PANCYTOPENIA 13 0.0002
846 INFLAMMATION 12 0.0002
847 SKIN CANCER 5 0.0002
848 PARANOIA 4 0.0002
849 ANXIETY 66 0.0002
850 RASH GENERALISED 6 0.0002
851 EXPOSURE VIA SKIN CONTACT 6 0.0002
852 HAEMORRHAGE 24 0.0002
853 GASTRITIS 6 0.0002
854 ADVERSE REACTION 3 0.0002
855 HYPERHIDROSIS 29 0.0002
856 RASH MACULO-PAPULAR 5 0.0002
857 LUNG DISORDER 11 0.0002
858 DYSKINESIA 9 0.0002
859 OSTEOMYELITIS 4 0.0002
860 TREATMENT NONCOMPLIANCE 12 0.0002
861 SKIN IRRITATION 10 0.0002
862 MUSCLE TWITCHING 5 0.0002
863 BLOOD GLUCOSE ABNORMAL 4 0.0002
864 GENERAL PHYSICAL HEALTH DETERIORATION 25 0.0002
865 DEEP VEIN THROMBOSIS 14 0.0002
866 CONDITION AGGRAVATED 65 0.0002
867 INTESTINAL OBSTRUCTION 8 0.0002
868 FRACTURE 4 0.0002
869 DISEASE PROGRESSION 25 0.0002
870 THERAPEUTIC RESPONSE SHORTENED 7 0.0002
871 RASH ERYTHEMATOUS 10 0.0002
872 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 10 0.0002
873 DIABETIC KETOACIDOSIS 5 0.0002
874 HERNIA 4 0.0002
875 DEPRESSION 47 0.0002
876 LIVER FUNCTION TEST ABNORMAL 6 0.0002
877 UNDERDOSE 15 0.0002
878 DEVICE ISSUE 18 0.0002
879 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 11 0.0002
880 LOWER RESPIRATORY TRACT INFECTION 9 0.0002
881 BLOOD COUNT ABNORMAL 3 0.0002
882 HAEMATEMESIS 5 0.0002
883 CEREBRAL HAEMORRHAGE 7 0.0002
884 THERAPY CESSATION 10 0.0002
885 CARDIAC ARREST 16 0.0002
886 DRUG EFFECT INCOMPLETE 7 0.0002
887 NERVOUS SYSTEM DISORDER 6 0.0002
888 BLOOD LACTATE DEHYDROGENASE INCREASED 3 0.0002
889 COMA 9 0.0002
890 ABSCESS 3 0.0002
891 METABOLIC ACIDOSIS 6 0.0002
892 JOINT INJURY 4 0.0002
893 PRODUCT USE IN UNAPPROVED INDICATION 46 0.0002
894 BLOOD BILIRUBIN INCREASED 5 0.0002
895 INCORRECT PRODUCT ADMINISTRATION DURATION 4 0.0002
896 DEVICE LEAKAGE 8 0.0002
897 SLEEP DISORDER 13 0.0002
898 SEPTIC SHOCK 8 0.0002
899 PLASMA CELL MYELOMA 7 0.0002
900 PULMONARY EMBOLISM 17 0.0002
901 PULMONARY OEDEMA 8 0.0002
902 THERAPEUTIC PRODUCT EFFECT DECREASED 8 0.0002
903 RASH PAPULAR 4 0.0002
904 MULTIPLE ORGAN DYSFUNCTION SYNDROME 5 0.0002
905 ACUTE KIDNEY INJURY 26 0.0002
906 BRADYCARDIA 9 0.0002
907 WITHDRAWAL SYNDROME 7 0.0002
908 IRRITABILITY 10 0.0002
909 INTERSTITIAL LUNG DISEASE 8 0.0002
910 RENAL FAILURE ACUTE 7 0.0002
911 ENCEPHALOPATHY 4 0.0002
912 ABASIA 4 0.0002
913 DEVICE DISLOCATION 7 0.0002
914 MULTIPLE SCLEROSIS RELAPSE 11 0.0002
915 PNEUMONIA ASPIRATION 4 0.0002
916 CHRONIC KIDNEY DISEASE 12 0.0002
917 FLUID RETENTION 8 0.0002
918 DEVICE MALFUNCTION 11 0.0002
919 INJECTION SITE PAIN 48 0.0002
920 HEPATITIS 4 0.0002
921 DRUG RESISTANCE 4 0.0002
922 LACTIC ACIDOSIS 5 0.0002
923 DEPRESSED LEVEL OF CONSCIOUSNESS 6 0.0002
924 ACTIVITIES OF DAILY LIVING IMPAIRED 3 0.0002
925 DEPRESSED MOOD 8 0.0002
926 AGITATION 11 0.0001
927 CARDIAC FAILURE 12 0.0001
928 URTICARIA 25 0.0001
929 FEAR 4 0.0001
930 ANGER 5 0.0001
931 ARRHYTHMIA 7 0.0001
932 BODY TEMPERATURE INCREASED 3 0.0001
933 TACHYCARDIA 13 0.0001
934 HAEMATURIA 5 0.0001
935 ACNE 11 0.0001
936 ABNORMAL DREAMS 4 0.0001
937 THROMBOCYTOPENIA 16 0.0001
938 HYPERKALAEMIA 5 0.0001
939 MENTAL DISORDER 6 0.0001
940 NEEDLE ISSUE 4 0.0001
941 DEVICE DIFFICULT TO USE 9 0.0001
942 ACUTE MYOCARDIAL INFARCTION 4 0.0001
943 PSYCHOTIC DISORDER 4 0.0001
944 INJECTION SITE MASS 5 0.0001
945 DERMATITIS ATOPIC 7 0.0001
946 DRUG INTERACTION 21 0.0001
947 APPLICATION SITE PRURITUS 3 0.0001
948 MYOCARDIAL INFARCTION 23 0.0001
949 INJECTION SITE SWELLING 10 0.0001
950 ALANINE AMINOTRANSFERASE INCREASED 8 0.0001
951 BREAST CANCER 12 0.0001
952 DEATH 110 0.0001
953 MALIGNANT NEOPLASM PROGRESSION 13 0.0001
954 INJECTION SITE BRUISING 10 0.0001
955 HYPOGLYCAEMIA 6 0.0001
956 MATERNAL EXPOSURE DURING PREGNANCY 11 0.0001
957 CEREBRAL INFARCTION 3 0.0001
958 PRODUCT SUBSTITUTION ISSUE 7 0.0001
959 ADVERSE EVENT 11 0.0001
960 ANAPHYLACTIC SHOCK 3 0.0001
961 NEOPLASM PROGRESSION 4 0.0001
962 APPLICATION SITE ERYTHEMA 3 0.0001
963 INCORRECT ROUTE OF DRUG ADMINISTRATION 4 0.0001
964 ELECTROCARDIOGRAM QT PROLONGED 4 0.0001
965 NEUTROPENIA 15 0.0001
966 HYPERGLYCAEMIA 4 0.0001
967 TREATMENT FAILURE 9 0.0001
968 RENAL DISORDER 5 0.0001
969 RENAL IMPAIRMENT 9 0.0001
970 RENAL FAILURE 14 0.0001
971 BLOOD CREATINE PHOSPHOKINASE INCREASED 3 0.0001
972 INJECTION SITE HAEMORRHAGE 8 0.0001
973 EMOTIONAL DISTRESS 12 0.0001
974 DEVICE BREAKAGE 4 0.0001
975 SUICIDAL IDEATION 9 0.0001
976 ANGIOEDEMA 4 0.0001
977 MEDICATION ERROR 5 0.0001
978 CONVULSION 5 0.0001
979 INJECTION SITE REACTION 6 0.0001
980 MULTIPLE SCLEROSIS 4 0.0001
981 INJECTION SITE ERYTHEMA 10 0.0001
982 AGGRESSION 4 0.0001
983 PSORIASIS 10 0.0001
984 INJECTION SITE PRURITUS 5 0.0001
985 NO ADVERSE EVENT 13 0.0001
986 INTENTIONAL OVERDOSE 4 0.0001
987 DRUG ABUSE 5 0.0001
988 TOXICITY TO VARIOUS AGENTS 8 0.0000
989 DRUG WITHDRAWAL SYNDROME 4 0.0000
990 OVERDOSE 9 0.0000
991 DRUG DEPENDENCE 6 0.0000